2024
| |
| |
|---|
Date
| Number
| Subject
| Targeted Provider
|
|---|
December 13, 2024
| 270
| Maryland Medicaid's Preferred Drug List (PDL) - January 1, 2025
| Pharmacists, Physicians, Pharmacies
|
|---|
November 15, 2024
| 269
| Brand vs Generic (DAW6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians, and Pharmacies
|
|---|
October 29, 2024
| 268
| COVID-19 Home Test Kit Coverage (2024 UPDATE)
| Pharmacists, Physicians, and Pharmacies
|
|---|
Octobet 29, 2024
| 267
| COVID-19 Vaccine Reimbursement (2024 UPDATE)
| Pharmacists, Physicians, and Pharmacies
|
|---|
October 29, 2024
| 266
| Coverage of Oral Antivirals for the Treatment of COVID-19 (2024 UPDATE)
| Pharmacists, Physicians, and Pharmacies
|
|---|
October 1, 2024
| 265
| Change of Pharmacy Benefits Manager (PBM) for Maryland Physicians Care (MPC)
| Pharmacists and Pharmacies
|
|---|
August 1, 2024
| 264
| Brand vs Generic (DAW6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians, and Pharmacies
|
|---|
June 20, 2024
| 263
| Maryland Medicaid's Preferred Drug List (PDL) - July 1, 2024
| Pharmacists, Physicians, and Pharmacies
|
|---|
May 10, 2024
| 262
| Maryland Medicaid Prescriber Enrollment & Pharmacy Claim Processing Requirement
| Pharmacists, Physicians, and Pharmacies
|
|---|
April 24, 2024
| 261
| Brand vs Generic (DAW6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians, and Pharmacies
|
|---|
April 11, 2024
| 260
| COVID-19 Home Test Kit Coverage (2024 UPDATE)
| Pharmacists, Physicians, and Pharmacies
|
|---|
March 13, 2024
| 259
| Brand vs Generic (DAW6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians, and Pharmacies
|
|---|
2023
| |
|
|
|---|
Date
| Number
| Subject
| Targeted Provider
|
|---|
December 28, 2023
| 258
| Pharmacists Professional Services (UPDATED)
| Pharmacists
|
|---|
December 26, 2023
| 257
| Pharmacists Professional Services
| Pharmacists
|
|---|
December 21, 2023
| 256
| Brand vs Generic (DAW6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians, and Pharmacies
|
|---|
December 14, 2023
| 255
| Maryland Medicaid Prescriber Enrollment & Pharmacy Claim Processing Requirement
| Pharmacists, Physicians and Pharmacies
|
|---|
December 11, 2023
| 254
| Maryland Medicaid's Preferred Drug List (PDL)- January 1, 2024
| Pharmacists, Physicians and Pharmacies
|
|---|
December 9, 2023
| 253
| Brand vs Generic (DAW6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians and Pharmacies
|
|---|
September 29. 2023
| 252
| COVID-19 Vaccine Reimbursement- UPDATE
| Pharmacists, Physicians and Pharmacies
|
|---|
September 15, 2023
| 251
| COVID-19 Home Test Kit Coverage (UPDATE)
| Pharmacists, Physicians and Pharmacies
|
|---|
September 8, 2023
| 250
| Brand vs Generic (DAW6) Changes to Maryland Medicaid’s Preferred Drug List (PDL)
| Pharmacists, Physicians and Pharmacies
|
July 7, 2023
| 249
| Brand vs Generic (DAW6) Changes to Maryland Medicaid’s Preferred Drug List (PDL)
| Pharmacists, Physicians and Pharmacies
|
June 13, 2023
| 248
| Maryland Medicaid's Preferred Drug List (PDL) - July 1, 2023
| Pharmacists, Physicians and Pharmacies
|
May 23, 2023
| 247
| Brand Vs Generic (DAW 6) Changes to Maryland Medicaid's Preferred Drug List (PDL)
| Pharmacists, Physicians and Pharmacies
|
2022
|
|
Date |
Number |
Subject |
Targeted Provider |
December 30, 2022
| 246
|
Advisory 246 Maryland's Preferred Drug List effective 1-1-2023 |
October 3, 2022
| 245
|
Advisory 245 Generic ProAir HFA is Preferred on PDL
|
August 29, 2022
| 244
|
Advisory 244 Amendment to Advisory #243 Brand VS Generic (DAW6)
|
August 9, 2022
| 243
|
Brand vs Generic (DAW6) Changes to Maryland Medicaid’s Preferred Drug List (PDL)
|
July 06, 2022
| 242
|
Advisory 242 Brand Viibryd is preferred on Maryland Medicaid Preferred Drug List (PDL)
|
June 10, 2022
| 241
|
Advisory 241 Maryland's Preferred Drug List Effective July 1, 2022
|
February 9, 2022
| 240-a
|
Advisory 240-a Coverage of Oral Antivirals for the Treatment of COVID-19
|
February 8, 2022
| 240
|
Advisory 240 COVID-19 Home Test Kit Coverage
|
January 26, 2022
| 239
| Brand vs Generic (DAW6) Changes to Maryland Medicaid’s Preferred Drug List (PDL)
|
2021
|
|
Date |
Number |
Subject |
Targeted Provider |
December 16, 2021
| 238
| | Pharmacists, Physicians and Pharmacies
|
December 14, 2021
| 237
| Maryland Medicaid’s Preferred Drug List (PDL) – January 1, 2022
| Pharmacists, Physicians and Pharmacies
|
December 10, 2021
| 236
| | Pharmacists, Physicians and Pharmacies
|
December 10, 2021
| 235
| | Pharmacists, Physicians and Pharmacies
|
November 17
| 234
| Update of Nutritional Prior Authorization (DHMH 3495) Form
| Pharmacists, Physicians and Pharmacies
|
November 15
| 233
| Updated Hepatitis C Prior Authorization Form
| Pharmacists, Physicians and Pharmacies
|
October 4
| 232
| Concurrent use of Opioids and Medication Assisted Treatment (MAT)
| Pharmacists, Physicians and Pharmacies
|
September 1
| 231
|
Pharmacy Provider Guidance on COVID-19 Additional Vaccine Dose
| Pharmacists and Pharmacies
|
August 4
| 230
|
Resumption of COVID-19 Emergency Activity Prior Authorization Requirements
| Pharmacists and Pharmacies
|
July 12
| 229 |
MDH Office of Pharmacy Services Call Center Helpline Return to Live Call Operations | Pharmacists and Pharmacies |
| June 23 | 228
|
Elimination of Signature-less Deliveries of Pharmaceuticals | Pharmacists and Pharmacies |
| June 18 | 227
|
Maryland's Preferred Drug List effective 7-1-21 | Pharmacists, Physicians and Pharmacies |
| April 21 | 226 |
Changes to DAW6 Drug Program | Pharmacists and Pharmacies |
| April 20 | 225 |
Opioid Naive Participants | Pharmacists and Pharmacies |
| March 23 | 224 |
COVID-19 Vaccine Incentive Fee Increase - UPDATE | Pharmacists and Pharmacies |
| January 29 | 223 |
Nutritional Supplements | Pharmacists and Pharmacies |
| January 27 | 222 |
Updated Professional Dispensing fees | Pharmacists and Pharmacies |
| January 12 | 221 |
Updated Pharmacy Provider Guidance | Pharmacists and Pharmacies |
|
|
2020 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 18 | 220 |
Maryland's Preferred Drug List effective 1-1-2021 | Pharmacists, Pharmacies and Physicians |
| December 11 | 219 |
Pharmacy Provider Guidance on COVID-19 Vaccines Administration | Pharmacists and Pharmacies |
| November 17 | 218 |
Brand Bethkis is Preferred on PDL. | Pharmacists and Pharmacies |
| October 20 | 217 |
Pharmacy Provider Guidance on Vaccines | Pharmacists and Pharmacies |
| September 22 | 216 |
Quantity Prescribed Field Required for Schedule II Drugs | Pharmacists, Pharmacies and Physicians |
| August 10 | 215 |
Testing for COVID-19 by Medicaid Pharmacies - Follow-up Guidance (updated) | Pharmacists and Pharmacies |
| June 17 | 214 |
Maryland's Preferred Drug List 7-1-20 | Pharmacists, Pharmacies and Physicians |
| June 10 | 213 |
Testing for COVID-19 by Medicaid Pharmacies - Follow-up Guidance | Pharmacists and Pharmacies |
| May 29 | 212 |
Testing for COVID-19 by Medicaid Pharmacies | Pharmacists and Pharmacies |
| April 22 | 211 |
MDH Office of Pharmacy Services Call Center Helpline Changes to Voicemail System | Pharmacists, Pharmacies, Physicians and Consumers |
| April 7 | 210 |
14-day supply emergency override | Pharmacists and Pharmacies |
| April 3 | 209 |
Signature-less Deliveries of Pharmaceuticals - Follow-up Guidance | Pharmacists and Pharmacies |
| April 1 | 208 |
Signature-less Deliveries of Pharmaceuticals | Pharmacists and Pharmacies |
| March 27 | 207 |
14-day emergency supply | Pharmacists and Pharmacies |
| March 12 | 206 |
Waiving Early Refill Edits | Pharmacists, Pharmacies and Physicians |
| February 13 | 205 |
Removal of Adderall XR from DAW6 | Pharmacists and Pharmacies |
|
|
2019 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 13 | 204 |
Preferred Drug List 1.1.2020 | Pharmacists, Pharmacies and Physicians |
| December 10 | 203 |
Lyrica Capsules Removal from DAW6 | Pharmacists and Pharmacies |
| December 5 | 202 |
Carve-In of HIV-AIDS Medications to MCO | Pharmacists, Pharmacies and Providers |
| November 14 | 201 |
Hepatitis C CE Seminar | Providers and Pharmacists |
| October 23 | 200 |
Lyrica Oral solution Removal from DAW6 | Pharmacists and Pharmacies |
| July 26 | 199 |
Revatio | Pharmacists and Pharmacies |
| July 26 | 198 |
Brand Lyrica is Preferred | Pharmacists and Pharmacies |
| June 19 | 197 |
Maryland's Preferred Drug List | Pharmacists, Pharmacies and Physicians |
| April 5 | 196 |
Brand vs Generic DAW 6 changes | Pharmacists and Pharmacies |
| March 4 | 195 |
Suboxone Film now preferred | Pharmacists and Pharmacies |
| February 14 | 194 |
Brand vs Generic DAW 6 changes | Pharmacists and Pharmacies |
| January 24 | 193 |
Kapvay ER Removal from DAW6. 1.28.19 | Pharmacists and Pharmacies |
| January 23 | 192 |
Reyataz Removal from DAW6. 2.15.19 | Pharmacists and Pharmacies |
| |
|
2018 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 19 | 191 |
PDL Maryland's Preferred Drug List | Pharmacies, Pharmacists and Physicians |
| December 12 | 190 |
Carve Out of Spinraza and Cinryze | Pharmacies and Pharmacists |
| October 3 | 189 |
Diastat Removal from DAW 6 Program | Pharmacies, Pharmacists and Physicians |
| September 20 | 188 |
Carve Out of Lucemyra | Pharmacies and Pharmacists |
| August 3 | 187 |
Long Term Care Eligibility for Medicaid Recipients | Pharmacies and Pharmacists |
| June 29 | 186 |
DAW6 Suboxone Film | Pharmacies and Pharmacists |
| June 27 | 185 |
Preferred Drug List 7.1.18 | Pharmacists, Pharmacies and Consumers |
| April 24 | 184 |
Removal of Brand Invega | Pharmacists and Pharmacies |
| April 17 | 183 |
Norvir and Reyataz | Pharmacists and Pharmacies |
| April 16 | 182 |
Changes DAW6 | Pharmacists and Pharmacies |
| February 13 | 181 |
Tamiflu and it's generic Change on the PDL | Pharmacists and Pharmacies |
| February 2 | 180 |
Change in Online Preferred drug List | Pharmacists, Pharmacies and Consumers |
|
|
|
2017 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 20 | 179 |
Preferred Drug List 1.1.18 | Pharmacists, Pharmacies and Consumers |
| December 13 | 178 |
Sabril Powder Packet | Pharmacy, Pharmacists and Physicians |
| December 5 | 177
|
Carve-out of Ingrezza | Pharmacy, Pharmacists and Physicians |
| June 22 | 176 |
Maryland Preferred Drug List 7. 1 .17 | Pharmacists, Pharmacies and Consumers |
June 16
| 175 |
Changes in the Opiate Class | Pharmacists , Pharmacies and Consumers |
| May 12 | 174 |
Brand Metadate CD Removal from DAW 6 Program | Pharmacists and Pharmacies |
| April 5 | 173 |
FSS and Nominal Price Update | Pharmacists and Pharmacies |
| March 30 | 172 |
Change in Pharmacy Reimbursement Methodology | Pharmacists and Pharmacies |
| March 29 | 171 |
(correction) Removal of Brand Seroquel XR DAW6 | Pharmacists and Pharmacies |
| March 13 | 171 |
Removal of Brand Seroquel XR DAW6 | Pharmacists and Pharmacies |
|
|
|
2016 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 21 | 170 |
Maryland's Preferred Drug List 1 1 17 | Pharmacists, Pharmacies and Consumers |
| November 18 | 169 |
Seroquel XR DAW6 | Pharmacists and Pharmacies |
| October 26 | 168 |
Generic vs Brand Changes | Pharmacists and Pharmacies |
| October 19 | 167 |
Copay for Tobacco Cessation Products | Pharmacists, Pharmacies and Consumers |
| June 14 | 166 |
PDL as of 7/ 1/ 16 | Pharmacists, Pharmacies and Consumers |
| June 1 | 165 |
Zubsolv Preferred 6.1.16 | Pharmacists and Pharmacies |
| May 3 | 164 |
Gleevac® (Brand) tablets Is to Be Dispensed Over Its Generic | Pharmacists and Pharmacies |
| April 26 | 163 |
Nasonex® Nasal Spray 50 mcg Is Preferred (DAW6) Over Its Generic | Pharmacists and Pharmacies |
| March 3 | 162 |
Advisory 162 Brands | Pharmacists and Pharmacies |
| |
|
2015 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 17 | 161 |
PDL as of 1/1/2016 | Pharmacists, Pharmacies and Consumers |
| December 1 | 160 |
Brand Abilify | Pharmacists and Pharmacies |
| November 20 | 159 |
Invega Tablets on DAW 6 Program | Pharmacists and Pharmacies |
| September 30 | 158 |
Clozapine update_ REMS | Pharmacists and Pharmacies |
| July 9 | 157 |
Copaxone 20mg DAW6. | Pharmacists and Pharmacies |
| June 22 | 156 |
PDL as of 7/1/2015 | Pharmacists, Pharmacies and Consumers |
| May 12 | 155 |
Generic vs Brand | Pharmacists and Pharmacies |
| March 13 | 154 |
Quantity Limits | Pharmacists, Pharmacies, Physicians and Consumers |
|
|
|
2014 |
|
Date |
Number |
Subject |
Targeted Provider |
| December 19 | 153 |
PDL as of 1/1/2015
| Pharmacists, Pharmacies and Consumers |
| December 11 | 152 |
Intuniv DAW 6 | Pharmacists, Pharmacies, Physicians and Consumers |
| December 11 | 151 |
Carve Out of Substance Use Disorder Medications and Suboxone | Prescribers |
| December 5 | 150 |
Carve-Out of Substance Use Disorder Medications | Pharmacists and Pharmacies |
| October 10 | 149 |
How to prescribe Naloxone | Prescribers |
| September 12 | 148 |
Carve-Out of Naloxone | Pharmacists and Pharmacies |
| July 30 | 147 |
Tramadol as a Controlled Substance | Pharmacists, Physicians and Pharmacies |
| July 9 | 146 |
Changes in DAW 6 program | Pharmacists, Physicians and Pharmacies |
| June 17 | 145 |
PDL as of 07/01/14 | Pharmacists, Physicians and Consumers |
| June 10 | 144 |
Quantity Limits | Pharmacists, Pharmacies, Physicians and Consumers |
| April 23 | 143 |
Autorefill and return to stock | Pharmacists and Pharmacies |
| April 11 | 142 |
QL Update | Pharmacists, Physicians and Consumers |
|
|
|
2013 |
| Date | Number | Subject | Targeted Provider |
| December 26 | 141 |
MD PDL | Pharmacists, Physicians and Consumers |
| December 19 | 140 |
Cymbalta | Pharmacists and Pharmacies |
| December 5 | 139 |
OTC Plan B no age limit | Pharmacists and Pharmacies |
| October 25 | 138 |
Update on MADAP Program | Pharmacists and Pharmacies |
| October 24 | 137 |
Extended Outage | Pharmacists and Pharmacies |
| October 15 | 136 |
PAC program | Pharmacists and Pharmacies
|
| October 9 | 135 |
Brand name Lidoderm | Pharmacists and Pharmacies |
| July 24 | 134 |
Peer Review Program Expansion 0 to 17 | Pharmacists, Pharmacies and Physicians |
| July 12 | 133 |
Some Brands Preferred over generics July 2013 | Pharmacists, Pharmacies and Physicians |
| May 29 | 131 |
Some Brands Preferred over generics June 2013 | Pharmacists and Pharmacies |
| April 1 | 130 |
72 hours emergency supply | Pharmacists and Pharmacies |
| January 8 | 129 |
Openings on P&T Committee | Pharmacists, Physicians and Consumers |
|
|
|
2012 |
|
Date |
Number |
Subjects |
Targeted Provider |
| December 28 | 128 |
Preferred Drug List Update | Pharmacies |
| December 20 | 127 |
Drug Coverage Changes for Full Duals | Pharmacies |
| December 17 | 126 |
Update on New Operating System for MMPP | Pharmacies |
| December 11 | 125 |
Holiday Payment Schedule | Pharmacies |
| November 27 | 124 |
Metadate CD Becomes a Preferred Brand in Medicaid | Pharmacies |
| November 7 | 123 |
Some Brands Preferred over generics Nov. 2012 | Pharmacies |
| November 7 | 122 |
No PA Required for Tier 2 Abilify for ages 10-17 | Prescribers |
| October 11 | 121 |
Ovide Will No Longer Be Brand Preferred | Pharmacies |
| October 4 | 120 |
New Operating System for MMPP | Pharmacies |
| September 19 | 119 |
Geodon Will No Longer Be Brand preferred | Pharmacies |
| September 18 | 118 |
Lexapro Will No Longer Be Brand Preferred | Pharmacies |
| September 14 | 117 |
Prior Authorization for Tier 2 and Non-preferred Antipsychotic Drugs | Pharmacies and Prescribers |
| August 7 | 116 |
New Web Address for Pharmacy Program | Pharmacies and Prescribers |
| July 20 | 115 |
Peer Review Programs Expanded to Include Children up to Age 10
| Pharmacies and Prescribers |
| July 3 | 114 |
Changes in Preferred Brands vs Generics: Kadian and Roxicodone | Pharmacies |
| June 27 | 113 |
Preferred Drug List July 1, 2012 | Prescribers and Pharmacies |
| June 8 | 112 |
Updates to List of Brand Drugs Preferred vs Generics on the Maryland Medicaid Preferred | Pharmacies and Prescribers |
| May 30 | 111 |
Lipitor No Longer Brand Preferred on Maryland Medicaid Preferred Drug List | Prescribers and Pharmacies |
| April 25 | 110 |
Medicaid Prefers Brands Lexapro and Geodon | Pharmacies and Prescribers |
| February 3 | 109 |
Medicaid Temporarily Authorizes Brand Prevacid Solutabs | Prescribers and Pharmacies |
| January 4 | 108 |
Late Refills for HIV Drugs - Again | Pharmacies |
|
2011
|
|
Date |
Number |
Subjects |
Targeted Provider |
| December 29 | 107 |
Preferred Drug List Update | Pharmacies and Prescribers |
| December 29 | 106 |
Cost of Dispensing Analysis | Pharmacies |
| December 21 | 105 |
Holiday Payment Schedule | Pharmacies |
| December 20 | 104 |
Transition to D.0 | Pharmacies |
| December 20 | 103 |
Transition to D.0 for LTC Pharmacies | Pharmacies |
| December 13 | 102 |
Changes in Preferred Multisource Brands on PDL, Use DAW 6 | Prescribers and Pharmacies |
| December 5 | 101 |
Clarify Regulation Changes | Pharmacies |
| November 30 | 100 |
Pharmacy Services Regulation Changes | Pharmacies |
| November 4 | 99 |
Late Refills for HIV/AIDS Medications | Pharmacies and Prescribers |
| October 7 | 98 |
Peer Review Program for Antipsychotics | Pharmacies and Prescribers |
| June 30 | 97 |
Preferred Drug List Update
| Pharmacies and Prescribers |
| June 29 | 96 |
Dispensing Fee Changes
| All Pharmacies |
| June 28 | 95 |
Preferred Brands on the PDL, Use DAW 6 | Pharmacies and Prescribers |
| June 27 | 94 |
Corrective Managed Care Programs and Misuse of Controlled Substances | Pharmacies |
| June 23 | 93 |
Quantity Limits and Dose Optimization | Physicians and Pharmacies |
| May 13 | 92 |
OIG Audits | Pharmacies |
| May 13 | 91 |
List of Preferred Multisource Brands Has Changed | Prescribers and Pharmacies |
| April 29 | 90 |
Notice of Survey for Dispensing Fee | Pharmacies |
| March 23 | 89 |
Kapvay for Ages 6-17 Moved to Mental Health Carve-Out | Pharmacies and Prescribers |
| February 25 | 88 |
Important Changes Related to Prior Authorization Requests for Fee-for-Service Members | Pharmacies and Prescribers |
|
|
2010 |
|
Date |
Number |
Subjects |
Targeted Provider |
| September 30 | 87 |
Generic vs Brand on the Preferred Drug List | Prescribers and Pharmacies |
| September 30 | 86 |
Updated Preferred Drug List Effective October 1, 2010 | Prescribers and Pharmacies |
| July 19 | 85 |
Reminder: Tamper Resistant Prescriptions Required for Medicaid Rx | Prescribers and Pharmacies |
| June 28 | 84 |
Intuniv Moved to Mental Health Formulary for MCO Members Aged 6-17 Effective July 1, 2010 | Prescribers and Pharmacies |
| April 16 | 83 |
Limited Coverage of OTC Drugs for Dual Eligibles | Prescribers and Pharmacies |
| April 1 | 82 |
Few Exceptions to Generic Substitution | Prescribers and Pharmacies |
| March 31 | 81 |
Preferred Drug List Effective April 1, 2010 | Prescribers and Pharmacies |
| March 13 | 80 |
Over the Counter Plan B Coverage | Pharmacies |
| February 9 | 79 |
Rubber Stamped Prescribed Are Invalid | Prescribers and Pharmacies |
| January 26 | 78 |
Effective handling of Claim Rejections | Pharmacies |
|
|
|
2009 |
|
Date |
Number |
Subjects |
Targeted Provider |
| December 18 | 77 |
Holiday Closings | Pharmacies and Prescribers |
| October 9 | 76 |
Update on mass Adjustments of legend Insulins | Pharmacies |
| October 1 | 75 |
Over-the-Counter Plan B Coverage Up-Date | Pharmacies |
| October 2 | 74 |
Some Multisource Brand Name Drugs Preferred Over Generics | Pharmacies and Prescribers |
| October 1 | 73 |
Preferred Drug List Effective October 1, 2009 | Pharmacies and Prescribers |
| October 1 | 72 |
Changes for the Status of Antipsychotic Medication on Preferred Drug List | Prescribers |
| September 30 | 71 |
30-Day Emergency Supply of Atypical Antipsychotics | Pharmacies |
| September 24 | 70 |
Mass Adjustment for Legend Insulins | Pharmacies |
| June 29 | 69 |
Changes in Mental Health Carve Out | Pharmacies and Prescribers |
| May 19 | 68 |
New Denial Codes for Non-rebatable Drugs, DESI and Obsolete Drugs | Pharmacies |
| April 22 | 67 |
Not all Generics are Preferred | Pharmacies and Prescribers |
| April 9 | 66 |
Preferred Drug List Effective April 1, 2009 | Pharmacies and Providers |
| April 7 | 65 |
Maryland Medicaid May Cover up to a 30-day Emergency Supply of Atypical Antipsychotics | Pharmacies |
| March 24 | 64 |
Time Limit Extended for Filing Claims | Pharmacies |
| February 18 | 63 |
Prescriber NPI Required on Pharmacy Claims, Effective March 1, 2009 | Prescribers |
| February 18 | 62 |
Claim Must Have Prescriber NPI | Pharmacies |
|
|
|
2008 |
|
Date |
Number |
Subjects |
Targeted Provider |
| December 22 | 61 |
Pharmacy Hotline Holiday Schedule | Pharmacies |
| December 9 | 60 |
Depo-medroxyprogesterone | Pharmacies |
| December 18 | 59 |
Payments Delayed One Week | Pharmacies |
| September 24 | 58 |
30-day Emergency Supply May be Available for Atypical Antipsychotic Prescriptions | Pharmacies |
| September 22 | 57 |
Required Tamper-resistant Pad Features Effective October 1, 2008 | Pharmacies |
| September 22 | 56 |
Required Tamper-resistant Prescription Pad Features Effective October 1, 2008 | Prescribers |
| September 18 | 55 |
Automatic Correction of Underpayments for CellCept, Lunesta, Xopenex, Fuseon kit and Travatan Z Claims | Pharmacies |
| September 12 | 54 |
Scheduled Down Time for Medicaid Claims Processing System | Pharmacies |
| August 20 | 53 |
Physician Administered Medications | Prescribers |
| July 16 | 52 |
Intervention Codes | Pharmacies |
| July 15 | 51 |
Pain Management Agreements | Prescribers |
| June 25 | 50 |
Information about Formularies, PDL and PAs at Epocrates.com and DHMH website | Prescribers and Pharmacies |
| May 2 | 49 |
Prescriber NPI | Pharmacies |
| April 11 | 48 |
POS System Maintenance | Pharmacies |
| April 3 | 47 |
Preferred Drug List, effective April 1, 2008 | Prescribers and Pharmacies |
| March 26 | 46 |
NPI Information for Prescribers | Prescribers and Pharmacies |
| March 7 | 45 |
Tamper Resistant Prescription Pad Features to be Phased in Beginning April 1, 2008 | Prescribers and all Pharmacies |
| February 26 | 44 |
Reminder: At Least One Recognized Tamper Resistant Feature Required as of April 1, 2008 on all Written Medical Prescriptions | Prescribers and all Pharmacies |
| February 12 | 43 |
Temporary Technical Difficulty Processing Medstar Family Choice Claims | All Pharmacies |
| February 6 | 42 |
March 1- NPI Required on Claims | Providers |
|
|
2007
|
|
Date |
Number |
Subjects |
Targeted Provider |
| December 27 | 41 |
Atypical Antipsychotics, Zyprexa Step Therapy, AIDS/HIV Drugs Carved Out from MCOs, Refills of Controlled Drugs | Providers and Prescribers |
| October 1 | 40 |
Tamper-Resistant Prescription Pads Are Delayed Until April 1, 2008 | Prescribers and all Pharmacies |
| August 29 | 39 |
Changes to Preferred Drug List | Prescribers and all Pharmacies |
| May 9 | 38 |
Correction of Underpayments, Over-the-Counter Plan B Coverage, Clinical Criteria for Cymbalta, Coordination of Benefits | Prescribers and all Pharmacies |
| April 12 | 37 |
Possible Underpayments, Unacceptable Prescriber DEA Numbers, Early Refills for Recently Discharged Long Term Care | Prescribers and all Pharmacies |
| March 28 | 36 |
Explanations of Some Claim Rejection Messages, New EVS Inquiry Phone Number, NPI Reminder, and Changes to Preferred Drug List (PDL) effective April 2007 | All Pharmacies |
| February 9 | 35 |
Late Payments | All Pharmacies |
| February 5 | 34 |
New Medicaid POS Claims Processor | All Pharmacies |
| January 24 | 33 |
POS System To Be Shutdown: New Fax Numbers for PAs | All Pharmacies |
| January 17 | 32 |
Reminder - POS Provider Training | All Pharmacies |
|
|
2006
|
|
Date |
Number |
Subjects |
Targeted Provider |
| December 21 | 31 |
New POS Processor; Zocor®; Prescription Transfers; Part D Questions | All Pharmacies |
| October 5 | 30 |
Pharmacy Dispensing Fee Survey | All Pharmacies |
| September 27 | 29 |
Changes to the Preferred Drug List; New EVS System; Narrow Therapeutic Index Drugs | Prescribers and all Pharmacies |
| July 28 | 28 |
Brand Name PDL Anomalies Useful Medicare Part D Phone Numbers | Prescribers and all Pharmacies |
| June 29 | 27 |
New Primary Adult Care | Prescribers and all Pharmacies |
| May 11 | 26 |
New Primary Adult Care Program (PAC) Medicare Part D Exception and Prior Authorization Request Form | Prescribers and all Pharmacies |
| March 23 | 25 |
Revised Preferred Drug List Transition from Pharmacy Assistance to Medicare Part D | Prescribers and All Pharmacies |
| March 2 | 24 |
Dummy DEA Numbers Medicare Pare D Issues | All Pharmacies |
| February 22 | 23 |
Changes to the Preferred Drug List (PDL) Effective April 2006 | Prescribers and all Pharmacies |
| January 10 | 22 |
Useful Medicare Phone Numbers & Medicaid Coverage of Drug Classes Excluded from Medicare Part D Basic Plans | All Pharmacies |
|
|
|
2005 |
|
Date |
Number |
Subjects |
Targeted Provider |
| December 16 | 21A |
Temporary Suspension of Early Refill Edits for Medicare Recipients | Prescribers |
| December 14 | 21 |
Temporary Suspension of Early Refill Edits for Medicare Recipients | All Pharmacies |
| November 23 | 20 |
Medicare Part D | Prescribers and all Pharmacies |
| September 16 | 19 |
Changes to the Preferred Drug List (PDL) Step Therapy for Stimulants and Related Agents Revised Quantity Limits for Emend | Prescribers and all Pharmacies |
| September 12 | 18 |
Hurricane Katrina Evacuees and Maryland Medicaid Program | Prescribers and all Pharmacies |
| June 23 (Revised June 28) | 17 |
Revised Preferred Drug List
Special Grandfathering for Norvasc, Coreg and Zetia
Safety Concerns for Certain Generics
Antimigraine (Triptan) Quantity Limits | Prescribers and all Pharmacies |
| April 28 | 16 |
Claims Processing Upgrade Notes | All Pharmacies |
| April 13 | 15 |
Planned Claims Processing System Maintenance | All Pharmacies |
| March 1 | 14
|
Further Clarification: Atypical Antipsychotic Dose Optimization Appropriate Use of Palladone Grandfathering Non-Preferred Mental Health Drugs | Prescribers and all Pharmacies |
|
|
2004 |
|
|
2003
|
|
Date |
Number |
Subjects |
Targeted Provider |
| December 12 | 4 |
Revised Preferred Drug List (PDL): Cumulative Update for Prescribers | Prescribers |
| November 3 | 3 |
Preferred Drug List (PDL Implementation) PDL Instructions for the Prescriber | Prescribers |
| October 31 | 2 |
Preferred Drug List (PDL Implementation) PDL Instructions for the Pharmacist | Community Pharmacies |
| October 9 | 1 |
Change in Pharmacy Assistance Co-pay | Community Pharmacies
|
|---|
